GENE ONLINE|News &
Opinion
Blog

2023-04-24| Special

Is ESG the Solution to Accelerate Agricultural Returns?

by Sahana Shankar
Share To
ESG practices to address environmental, societal and governance issues have emerged as powerful non-financial indicators to evaluate performances of businesses, in the last decade. The Covid-19 pandemic taught us how collective changes in consumer behaviour can make significantly impactful changes in global environmental challenges such as cutting down carbon emissions and limiting the acceleration of climate change. This has spurred a new wave of interest in both public and private sectors to invest in sustainability, social equity and energy-savings.

Agriculture is one of the sectors where ESG has had a huge impact and bigger returns, when implemented well. Here are some numbers to indicate how agriculture impacts all aspects of economy and business. Global estimate for the environmental cost of agriculture stands close to USD 3 trillion. It contributes to nearly a quarter of the global carbon footprint and provides livelihood to around 30% of the world’s population. Considering agriculture is vital to feed every one of the 8 billion people on the planet, it is a sector which has inspired innovation and still needs strong initiatives to maintain the fine balance in preserving our fragile ecosystems and increasing farm productivity in accordance with food demands. 

It's free! Log in now to read

LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top